(Q39561429)

13 September 2017

title

A randomized clinical trial of lithium in multiple system atrophy (English)

1 reference

13 September 2017

Francesco Saccà

1

1 reference

13 September 2017

Angela Marsili

2

1 reference

13 September 2017

Mario Quarantelli

3

1 reference

13 September 2017

Vincenzo Brescia Morra

4

1 reference

13 September 2017

Arturo Brunetti

5

1 reference

13 September 2017

Rosa Carbone

6

1 reference

13 September 2017

Chiara Pane

7

1 reference

13 September 2017

Giorgia Puorro

8

1 reference

13 September 2017

Cinzia Valeria Russo

9

1 reference

13 September 2017

Elena Salvatore

10

1 reference

13 September 2017

Tecla Tucci

11

1 reference

13 September 2017

Giuseppe De Michele

12

1 reference

13 September 2017

Alessandro Filla

13

1 reference

13 September 2017

publication date

30 August 2012

1 reference

13 September 2017

1 reference

13 September 2017

volume

260

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

458-461

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-012-6655-7

13 September 2017

exact match

0 references

cites work

Multiple system atrophy--the nature of the beast

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6655-7

Lithium induces autophagy by inhibiting inositol monophosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6655-7

α-Synuclein Is Degraded by Both Autophagy and the Proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6655-7

A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6655-7

Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6655-7

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6655-7

Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6655-7

Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6655-7

Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6655-7

Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6655-7

Second consensus statement on the diagnosis of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6655-7

Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6655-7

Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22932748

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00415-012-6655-7

1 reference

release_bt76mr35unbxrd4wglwlfk54ni

13 September 2017

Fatcat ID

0 references

1 reference